Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1009505.RASPEF3LHvUCm9_3vuIh9Tt5R8ExaxaARbVnsGQOzBT_o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1009505.RASPEF3LHvUCm9_3vuIh9Tt5R8ExaxaARbVnsGQOzBT_o130_assertion type Assertion NP1009505.RASPEF3LHvUCm9_3vuIh9Tt5R8ExaxaARbVnsGQOzBT_o130_head.
- NP1009505.RASPEF3LHvUCm9_3vuIh9Tt5R8ExaxaARbVnsGQOzBT_o130_assertion description "[KRAS mutations constitutively activate the RAS/RAF/mitogen-activated protein kinase (MAPK) pathway and therefore play an important role in anti-epidermal growth factor receptor therapy for patients with colorectal cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1009505.RASPEF3LHvUCm9_3vuIh9Tt5R8ExaxaARbVnsGQOzBT_o130_provenance.
- NP1009505.RASPEF3LHvUCm9_3vuIh9Tt5R8ExaxaARbVnsGQOzBT_o130_assertion evidence source_evidence_literature NP1009505.RASPEF3LHvUCm9_3vuIh9Tt5R8ExaxaARbVnsGQOzBT_o130_provenance.
- NP1009505.RASPEF3LHvUCm9_3vuIh9Tt5R8ExaxaARbVnsGQOzBT_o130_assertion SIO_000772 22938585 NP1009505.RASPEF3LHvUCm9_3vuIh9Tt5R8ExaxaARbVnsGQOzBT_o130_provenance.
- NP1009505.RASPEF3LHvUCm9_3vuIh9Tt5R8ExaxaARbVnsGQOzBT_o130_assertion wasDerivedFrom befree-2016 NP1009505.RASPEF3LHvUCm9_3vuIh9Tt5R8ExaxaARbVnsGQOzBT_o130_provenance.
- NP1009505.RASPEF3LHvUCm9_3vuIh9Tt5R8ExaxaARbVnsGQOzBT_o130_assertion wasGeneratedBy ECO_0000203 NP1009505.RASPEF3LHvUCm9_3vuIh9Tt5R8ExaxaARbVnsGQOzBT_o130_provenance.